These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36212998)

  • 1. Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis.
    Chen M; Zhang P; Li L; Yu Z; Liu N; Wang L
    Emerg Med Int; 2022; 2022():5314105. PubMed ID: 36212998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy.
    Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Clinical Efficacy and Safety of
    Guo YL; Gao F; Dong TW; Bai Y; Liu Q; Li RL; Yan ST; Chen M; Wei PF; Xi MM
    Evid Based Complement Alternat Med; 2021; 2021():6640594. PubMed ID: 34093720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis.
    Wu X; Huang Y; Zhang Y; He C; Zhao Y; Wang L; Gao J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials.
    Guo HB; Peng JQ; Xuan Wang ; Zhang KK; Zhong GZ; Chen WH; Shi GX
    BMC Nephrol; 2021 Sep; 22(1):304. PubMed ID: 34493223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials.
    Zheng W; Mei Y; Chen C; Cai L; Chen H
    Phytother Res; 2021 Jun; 35(6):2902-2924. PubMed ID: 33368709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis.
    Hong Y; Gui Z; Cai X; Lan L
    Open Med (Wars); 2016; 11(1):611-617. PubMed ID: 28352854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
    Jin D; Yu M; Li X; Wang X
    J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Tripterygium Glycoside in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis Based on the Duration of Medication.
    Li Y; Miao R; Liu Y; Zhang J; Dou Z; Zhao L; Zhang Y; Huang Z; Xia Y; Han D
    Front Endocrinol (Lausanne); 2021; 12():656621. PubMed ID: 33959100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic evaluation for efficacy of tripterygium glycosides in treating diabetic nephropathy stage IV].
    Huang J; Zhang JQ; Chen Z; Zhang Y; Chen WD; Wu XP
    Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3100-9. PubMed ID: 26677718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis.
    Song YH; Cai GY; Xiao YF; Wang YP; Yuan BS; Xia YY; Wang SY; Chen P; Liu SW; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):61. PubMed ID: 28193247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.
    Li Y; Zhu W; He H; Garov YA; Bai L; Zhang L; Wang J; Wang J; Zhou X
    Front Pharmacol; 2021; 12():691031. PubMed ID: 34177599
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Lengnan X; Ban Z; Haitao W; Lili L; Aiqun C; Huan W; Ping Z; Yonghui M
    Biomed Res Int; 2020; 2020():9181037. PubMed ID: 32596393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.